Filing Details
- Accession Number:
- 0001645627-17-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-18 10:48:20
- Reporting Period:
- 2017-05-15
- Filing Date:
- 2017-05-18
- Accepted Time:
- 2017-05-18 10:48:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,757,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,758,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,759,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,760,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,761,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,762,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,763,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,764,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,765,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,766,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,767,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,768,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,769,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,770,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,771,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,772,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,773,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,774,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,775,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,776,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,777,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,778,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,779,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,780,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,781,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,782,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,783,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,784,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,785,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-16 | 1,000 | $0.06 | 20,786,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
